A Phase I Study of Mozobil in the Treatment of Patients With WHIMS | MicrobiomeTrials← Back to trialsNCT00967785
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2010-01-06Est. Completion: 2026-08-06
Enrollment target: 14 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenzaCOVID - 19
Respiratory syncytial virus (RSV), influenza, and SARS-CoV-2 are common respiratory viruses. In healthy adults they usua…
Multiple LocationsEst. completion Dec 31, 2025
Coronavirus Disease 2019
Background:
COVID-19 is an acute respiratory syndrome. One symptom of COVID-19 is a reduction in the number of cells ca…
Washington D.C., United StatesCompleted Feb 20, 2025
Metastatic MelanomaRefractory Malignant Solid NeoplasmStage IV Cutaneous Melanoma AJCC v6 and v7Unresectable Malignant Solid Neoplasm
This phase I trial studies the side effects and best dose of cediranib maleate and selumetinib sulfate in treating patie…
Jacksonville, United StatesEst. completion Jun 6, 2019